[ English | Bahasa Malaysia ] Today is 22nd May 2019, 07:05 PM (Last updated: 14th May 2019)

Text Red Text Black Text Blue Text Green Text Smaller Text Reset Text Larger

Introduction to Molecular Pathology Unit

. Last Updated: 27 September 2018Hits: 19772

 

Introduction

The Molecular Pathology Unit was established in 1996, primarily to harness the latest advances in molecular biology and to use new cutting edge technologies in the biomedical sciences to carry out research on diseases in the country. 

A major focus of the Unit is on nasopharyngeal carcinoma (NPC), 5th most common cancer in Malaysia, for which very much less research is carried out worldwide compared to other major cancers.  In line with the National Strategic Plan for Cancer Control Programme (2016-2020) of the Ministry of Health Malaysia, the Unit focuses on research on NPC to improve prevention, early diagnosis and treatment of NPC.  The Unit also carries out collaborative research on other major cancers. The Unit utilizes and provides expertise on technologies to support cutting edge research as well as establishes platform technologies and develops pipelines for cancer research.

myGOV MAMPU JPA IKU MSC NMMR CRC MyHEALTH MOH Globinmed SPA krste.my

Notice

Logo-SIRIM-n-UKAS-IMR

IMR is a SIRIM accredited organisation (certificate number 2972).

This site is best viewed on Firefox (24.0) with resolution higher than 1280 x 768 pixels.

Our Location

world

Located at Jalan Pahang, 50588 Kuala Lumpur, Malaysia. We operate from 8.00am - 5.00pm Monday - Friday. Click on the map image to launch Google Maps service.

Get in touch with us